A Randomised Controlled Trial of Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Dipyridamole) in the Secondary Prevention of Stroke: Safety, Tolerability and Feasibility

Nikola Sprigg, Laura J. Gray, Tim England et al. · 2008

Read A Randomised Controlled Trial of Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Dipyridamole) in the Secondary Prevention of Stroke: Safety, Tolerability and Feasibility by Nikola Sprigg, Laura J. Gray, Tim England et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002852.txt.

Description

Work by Nikola Sprigg and colleagues appeared in PLOS ONE in 2008. Their subject was a randomised controlled trial of triple antiplatelet therapy (Aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility. Authorship is credited in the record to Nikola Sprigg and co-authors, with PLOS ONE as the journal of publication.

The opening of the abstract sets out the basis for the work. Aspirin, dipyridamole and clopidogrel are effective in secondary vascular prevention. Its abstract frames the work for later readers, who can judge the full text against the aims stated at the start.

Catalog record

CREATORNikola Sprigg, Laura J. Gray, Tim England et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002852

Browse the full library · About the Tower of Babel